The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis
Clinical trial NCT00372177 · COMPLETED
Trial details
- NCT number
- NCT00372177
- Sponsor
- Biotectid GmbH
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2008-05-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.